New York Governor Andrew Cuomo recently proposed government funding for a study to explore the impact of legalizing recreational marijuana in the state. State Senator Gustavo Rivera (D-NY) and High NY Founder and CEO Michael Zaystev discuss the state of regulation in New York.
"I am thankful that the governor put it in the budget. I am hoping it gets to the final version of the budget, and I am hoping we can actually make this happen in the state of New York sooner than later," said Rivera.
"I think he's also feeling some pressure from New Jersey's recent election," said Zaystev. Earlier this month newly elected New Jersey Governor expanded access to medicinal marijuana in the state through an executive order.
On whether this was political posturing, Rivera says while the government has been resistant to explore marijuana legislation in past couple years he does sense New York can get to the point where the state recognizes the opportunity to legalize recreational marijuana.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.